13 Hrs
Source:
Sharjah24
Sharjah24
Ready to play
Ready to play
The Russian Consumer Rights Protection Agency announced the approval of a new local medication called "Nuyok-14" for the treatment of infections caused by smallpox viruses, monkeypox, and cowpox. The drug, developed through collaboration between the state scientific center "Vector" and the Novosibirsk Institute of Organic Chemistry, aims to address the risks of monkeypox's spread amid its international outbreak, despite the World Health Organization declaring smallpox eradicated in 1980.
Notice: This Is an AI-Generated Summary
Comments (0)